Foundation thanks reporter Jennaphr Frederick at Fox News, Philadelphia, for her
story about Rocco and Tyler, shining the light on Dr Carole
Samango-Sprouse’s groundbreaking results and the need for early testing
and diagnosis. With national attention and stories like this one at
Fox, we can reach parents and their children across the country with the
message that there’s hope, and there is help, but we need to hurry!
And with the incredible work of Philadelphia families like George and
Melissa Stratts, chairing Focus Foundation’s largest annual fundraiser,
the Philadelphia Oktoberfest, we can raise the funds to continue the
research, support international clinics, and fund a global awareness
campaign for early diagnosis and treatment.
Back by popular demand, The Greater Philadelphia Fundraising Committee for the Focus Foundation will host our 4th annual Oktoberfest: "Under the Big Top"! This year, again enjoy the evening in downtown Philadelphia at the Crystal Tea Room with your friends and business associates. For more information, and to purchase tickets for the event, Click here.
The Focus Foundation is the first and only research-based agency exclusively dedicated to identifying and helping children who have X & Y Variations (also called X & Y Chromosomal Variations or Sex Chromosome Disorders; within the disorder are many sub-categories, which are identified by names including Klinefelter Syndrome, Tetrasomy X, Pentasomy X, 49 XXXXX, 48 XXXY, 49 XXXXY, XYY, and 47 XXY.), Dyslexia and/or Developmental Dyspraxia, conditions that lead to language-based disabilities, motor planning deficits, reading dysfunction, and attention and behavioral disorders. All physicians, ancillary health care providers and special educators are taught that genetic abnormalities can impact a child's development. Unfortunately, because most practitioners often receive insufficient information about these chromosome disorders, they don't even consider testing for X & Y Variations when caring for a child who presents with developmental concerns.
Early Identification + Targeted Treatment = Recovery